Instil Bio, Inc. TIL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -38.43% | -29.47% | -20.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -7.30% | -11.41% | -28.38% |
| Operating Income | -- | -- | 7.30% | 11.41% | 28.38% |
| Income Before Tax | -- | -- | 3.73% | 0.12% | 29.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | 3.73% | 0.12% | 29.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 3.73% | 0.12% | 29.33% |
| EBIT | -- | -- | 7.30% | 11.41% | 28.38% |
| EBITDA | -- | -- | 1.93% | 7.55% | 27.34% |
| EPS Basic | -- | -- | 5.38% | 1.40% | 29.72% |
| Normalized Basic EPS | -- | -- | 22.79% | 22.67% | 37.36% |
| EPS Diluted | -- | -- | 5.38% | 1.40% | 29.72% |
| Normalized Diluted EPS | -- | -- | 22.79% | 22.67% | 37.36% |
| Average Basic Shares Outstanding | -- | -- | 2.42% | 1.52% | 0.56% |
| Average Diluted Shares Outstanding | -- | -- | 2.42% | 1.52% | 0.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |